Publication | Open Access

Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial

MedicineCeritinib Versus ChemotherapyPathologyBronchial NeoplasmCancer TreatmentOncologyRadiation OncologyLung CancerMolecular Oncology